A Study of L-DOS47 in Combination With Vinorelbine/Cisplatin in Lung Adenocarcinoma
Clinical trial NCT03891173 · TERMINATED
Trial details
- NCT number
- NCT03891173
- Sponsor
- Helix BioPharma Corporation
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-02-19
- Primary completion
- 2020-05-22
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.